NCT04683211

Brief Summary

Iodine supplementation during pregnancy is recommended by the high health authority and by the World Health Organization during pregnancy. We would like to know if this supplementation is prescribed in a manner consistent with the recommendations in women diagnosed with gestational diabetes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 17, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 24, 2020

Completed
12 days until next milestone

Study Start

First participant enrolled

January 5, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 21, 2021

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 11, 2021

Completed
Last Updated

May 22, 2026

Status Verified

May 1, 2026

Enrollment Period

4 months

First QC Date

December 17, 2020

Last Update Submit

May 21, 2026

Conditions

Gestational Diabetes

Keywords

Iodine intakeiodine supplementationgestational diabetes

Outcome Measures

Primary Outcomes (1)

  • Iodine supplementation

    µg/day

    Day 0

Interventions

Evaluation of iodine supplementationOTHER

survey of iodine supplementation

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen with gestational diabetes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Women with gestational diabetes

You may qualify if:

  • pregnant woman with gestational diabetes
  • age ≥ 18 years
  • subject informed of the study and not having opposed it.

You may not qualify if:

  • already known pathology of the thyroid

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Sud Francilien

Corbeil-Essonnes, 91106, France

Location

MeSH Terms

Conditions

Diabetes, Gestational

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 17, 2020

First Posted

December 24, 2020

Study Start

January 5, 2021

Primary Completion

April 21, 2021

Study Completion

May 11, 2021

Last Updated

May 22, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)